0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rheumatic Disorders Treatment Market Research Report 2023
Published Date: November 2023
|
Report Code: QYRE-Auto-15X13281
Home | Market Reports | Health| Health Conditions| Arthritis
Global Rheumatic Disorders Treatment Market Research Report 2023
BUY CHAPTERS

Global Rheumatic Disorders Treatment Market Research Report 2023

Code: QYRE-Auto-15X13281
Report
November 2023
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rheumatic Disorders Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Rheumatic Disorders Treatment Market

Rheumatic Disorders Treatment Market

According to new survey, global Rheumatic Disorders Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rheumatic Disorders Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Rheumatic Disorders Treatment Market Report

Report Metric Details
Report Name Rheumatic Disorders Treatment Market
CAGR 5%
Segment by Type
  • Acts on TNF-α
  • Acts on Interleukins and Interleukin Receptors
  • Act on Protein Kinase
  • Against Cell Surface Antigens
  • Acts on Hormones and Hormone Receptors
Segment by Application
  • Hospital
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Humira, Enbrel, Simponi, Remicade, Rituxan, Stelara, Cosentyx, Prolia, Orencia, Actemra, Benlysta, Forteo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

Who are the main players in the Rheumatic Disorders Treatment Market report?

Ans: The main players in the Rheumatic Disorders Treatment Market are Humira, Enbrel, Simponi, Remicade, Rituxan, Stelara, Cosentyx, Prolia, Orencia, Actemra, Benlysta, Forteo

What are the Application segmentation covered in the Rheumatic Disorders Treatment Market report?

Ans: The Applications covered in the Rheumatic Disorders Treatment Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Rheumatic Disorders Treatment Market report?

Ans: The Types covered in the Rheumatic Disorders Treatment Market report are Acts on TNF-α, Acts on Interleukins and Interleukin Receptors, Act on Protein Kinase, Against Cell Surface Antigens, Acts on Hormones and Hormone Receptors

1 Rheumatic Disorders Treatment Market Overview
1.1 Product Overview and Scope of Rheumatic Disorders Treatment
1.2 Rheumatic Disorders Treatment Segment by Type
1.2.1 Global Rheumatic Disorders Treatment Market Value Comparison by Type (2023-2029)
1.2.2 Acts on TNF-α
1.2.3 Acts on Interleukins and Interleukin Receptors
1.2.4 Act on Protein Kinase
1.2.5 Against Cell Surface Antigens
1.2.6 Acts on Hormones and Hormone Receptors
1.3 Rheumatic Disorders Treatment Segment by Application
1.3.1 Global Rheumatic Disorders Treatment Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Rheumatic Disorders Treatment Market Size Estimates and Forecasts
1.4.1 Global Rheumatic Disorders Treatment Revenue 2018-2029
1.4.2 Global Rheumatic Disorders Treatment Sales 2018-2029
1.4.3 Global Rheumatic Disorders Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Rheumatic Disorders Treatment Market Competition by Manufacturers
2.1 Global Rheumatic Disorders Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Rheumatic Disorders Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Rheumatic Disorders Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Rheumatic Disorders Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Rheumatic Disorders Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rheumatic Disorders Treatment, Product Type & Application
2.7 Rheumatic Disorders Treatment Market Competitive Situation and Trends
2.7.1 Rheumatic Disorders Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rheumatic Disorders Treatment Players Market Share by Revenue
2.7.3 Global Rheumatic Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rheumatic Disorders Treatment Retrospective Market Scenario by Region
3.1 Global Rheumatic Disorders Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Rheumatic Disorders Treatment Global Rheumatic Disorders Treatment Sales by Region: 2018-2029
3.2.1 Global Rheumatic Disorders Treatment Sales by Region: 2018-2023
3.2.2 Global Rheumatic Disorders Treatment Sales by Region: 2024-2029
3.3 Global Rheumatic Disorders Treatment Global Rheumatic Disorders Treatment Revenue by Region: 2018-2029
3.3.1 Global Rheumatic Disorders Treatment Revenue by Region: 2018-2023
3.3.2 Global Rheumatic Disorders Treatment Revenue by Region: 2024-2029
3.4 North America Rheumatic Disorders Treatment Market Facts & Figures by Country
3.4.1 North America Rheumatic Disorders Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Rheumatic Disorders Treatment Sales by Country (2018-2029)
3.4.3 North America Rheumatic Disorders Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rheumatic Disorders Treatment Market Facts & Figures by Country
3.5.1 Europe Rheumatic Disorders Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Rheumatic Disorders Treatment Sales by Country (2018-2029)
3.5.3 Europe Rheumatic Disorders Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rheumatic Disorders Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Rheumatic Disorders Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Rheumatic Disorders Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Rheumatic Disorders Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Rheumatic Disorders Treatment Market Facts & Figures by Country
3.7.1 Latin America Rheumatic Disorders Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Rheumatic Disorders Treatment Sales by Country (2018-2029)
3.7.3 Latin America Rheumatic Disorders Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rheumatic Disorders Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Rheumatic Disorders Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Rheumatic Disorders Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Rheumatic Disorders Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rheumatic Disorders Treatment Sales by Type (2018-2029)
4.1.1 Global Rheumatic Disorders Treatment Sales by Type (2018-2023)
4.1.2 Global Rheumatic Disorders Treatment Sales by Type (2024-2029)
4.1.3 Global Rheumatic Disorders Treatment Sales Market Share by Type (2018-2029)
4.2 Global Rheumatic Disorders Treatment Revenue by Type (2018-2029)
4.2.1 Global Rheumatic Disorders Treatment Revenue by Type (2018-2023)
4.2.2 Global Rheumatic Disorders Treatment Revenue by Type (2024-2029)
4.2.3 Global Rheumatic Disorders Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Rheumatic Disorders Treatment Price by Type (2018-2029)
5 Segment by Application
5.1 Global Rheumatic Disorders Treatment Sales by Application (2018-2029)
5.1.1 Global Rheumatic Disorders Treatment Sales by Application (2018-2023)
5.1.2 Global Rheumatic Disorders Treatment Sales by Application (2024-2029)
5.1.3 Global Rheumatic Disorders Treatment Sales Market Share by Application (2018-2029)
5.2 Global Rheumatic Disorders Treatment Revenue by Application (2018-2029)
5.2.1 Global Rheumatic Disorders Treatment Revenue by Application (2018-2023)
5.2.2 Global Rheumatic Disorders Treatment Revenue by Application (2024-2029)
5.2.3 Global Rheumatic Disorders Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Rheumatic Disorders Treatment Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Humira
6.1.1 Humira Corporation Information
6.1.2 Humira Description and Business Overview
6.1.3 Humira Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Humira Rheumatic Disorders Treatment Product Portfolio
6.1.5 Humira Recent Developments/Updates
6.2 Enbrel
6.2.1 Enbrel Corporation Information
6.2.2 Enbrel Description and Business Overview
6.2.3 Enbrel Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Enbrel Rheumatic Disorders Treatment Product Portfolio
6.2.5 Enbrel Recent Developments/Updates
6.3 Simponi
6.3.1 Simponi Corporation Information
6.3.2 Simponi Description and Business Overview
6.3.3 Simponi Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Simponi Rheumatic Disorders Treatment Product Portfolio
6.3.5 Simponi Recent Developments/Updates
6.4 Remicade
6.4.1 Remicade Corporation Information
6.4.2 Remicade Description and Business Overview
6.4.3 Remicade Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Remicade Rheumatic Disorders Treatment Product Portfolio
6.4.5 Remicade Recent Developments/Updates
6.5 Rituxan
6.5.1 Rituxan Corporation Information
6.5.2 Rituxan Description and Business Overview
6.5.3 Rituxan Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Rituxan Rheumatic Disorders Treatment Product Portfolio
6.5.5 Rituxan Recent Developments/Updates
6.6 Stelara
6.6.1 Stelara Corporation Information
6.6.2 Stelara Description and Business Overview
6.6.3 Stelara Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Stelara Rheumatic Disorders Treatment Product Portfolio
6.6.5 Stelara Recent Developments/Updates
6.7 Cosentyx
6.6.1 Cosentyx Corporation Information
6.6.2 Cosentyx Description and Business Overview
6.6.3 Cosentyx Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cosentyx Rheumatic Disorders Treatment Product Portfolio
6.7.5 Cosentyx Recent Developments/Updates
6.8 Prolia
6.8.1 Prolia Corporation Information
6.8.2 Prolia Description and Business Overview
6.8.3 Prolia Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Prolia Rheumatic Disorders Treatment Product Portfolio
6.8.5 Prolia Recent Developments/Updates
6.9 Orencia
6.9.1 Orencia Corporation Information
6.9.2 Orencia Description and Business Overview
6.9.3 Orencia Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Orencia Rheumatic Disorders Treatment Product Portfolio
6.9.5 Orencia Recent Developments/Updates
6.10 Actemra
6.10.1 Actemra Corporation Information
6.10.2 Actemra Description and Business Overview
6.10.3 Actemra Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Actemra Rheumatic Disorders Treatment Product Portfolio
6.10.5 Actemra Recent Developments/Updates
6.11 Benlysta
6.11.1 Benlysta Corporation Information
6.11.2 Benlysta Rheumatic Disorders Treatment Description and Business Overview
6.11.3 Benlysta Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Benlysta Rheumatic Disorders Treatment Product Portfolio
6.11.5 Benlysta Recent Developments/Updates
6.12 Forteo
6.12.1 Forteo Corporation Information
6.12.2 Forteo Rheumatic Disorders Treatment Description and Business Overview
6.12.3 Forteo Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Forteo Rheumatic Disorders Treatment Product Portfolio
6.12.5 Forteo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rheumatic Disorders Treatment Industry Chain Analysis
7.2 Rheumatic Disorders Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rheumatic Disorders Treatment Production Mode & Process
7.4 Rheumatic Disorders Treatment Sales and Marketing
7.4.1 Rheumatic Disorders Treatment Sales Channels
7.4.2 Rheumatic Disorders Treatment Distributors
7.5 Rheumatic Disorders Treatment Customers
8 Rheumatic Disorders Treatment Market Dynamics
8.1 Rheumatic Disorders Treatment Industry Trends
8.2 Rheumatic Disorders Treatment Market Drivers
8.3 Rheumatic Disorders Treatment Market Challenges
8.4 Rheumatic Disorders Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Rheumatic Disorders Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Rheumatic Disorders Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Rheumatic Disorders Treatment Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Rheumatic Disorders Treatment Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Rheumatic Disorders Treatment Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Rheumatic Disorders Treatment Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Rheumatic Disorders Treatment Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Rheumatic Disorders Treatment Average Price (US$/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Rheumatic Disorders Treatment, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Rheumatic Disorders Treatment, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Rheumatic Disorders Treatment, Product Type & Application
    Table 12. Global Key Manufacturers of Rheumatic Disorders Treatment, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Rheumatic Disorders Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatic Disorders Treatment as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Rheumatic Disorders Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Rheumatic Disorders Treatment Sales by Region (2018-2023) & (K Units)
    Table 18. Global Rheumatic Disorders Treatment Sales Market Share by Region (2018-2023)
    Table 19. Global Rheumatic Disorders Treatment Sales by Region (2024-2029) & (K Units)
    Table 20. Global Rheumatic Disorders Treatment Sales Market Share by Region (2024-2029)
    Table 21. Global Rheumatic Disorders Treatment Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Rheumatic Disorders Treatment Revenue Market Share by Region (2018-2023)
    Table 23. Global Rheumatic Disorders Treatment Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Rheumatic Disorders Treatment Revenue Market Share by Region (2024-2029)
    Table 25. North America Rheumatic Disorders Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Rheumatic Disorders Treatment Sales by Country (2018-2023) & (K Units)
    Table 27. North America Rheumatic Disorders Treatment Sales by Country (2024-2029) & (K Units)
    Table 28. North America Rheumatic Disorders Treatment Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Rheumatic Disorders Treatment Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Rheumatic Disorders Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Rheumatic Disorders Treatment Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Rheumatic Disorders Treatment Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Rheumatic Disorders Treatment Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Rheumatic Disorders Treatment Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Rheumatic Disorders Treatment Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Rheumatic Disorders Treatment Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Rheumatic Disorders Treatment Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Rheumatic Disorders Treatment Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Rheumatic Disorders Treatment Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Rheumatic Disorders Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Rheumatic Disorders Treatment Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Rheumatic Disorders Treatment Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Rheumatic Disorders Treatment Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Rheumatic Disorders Treatment Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Rheumatic Disorders Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Rheumatic Disorders Treatment Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Rheumatic Disorders Treatment Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Rheumatic Disorders Treatment Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Rheumatic Disorders Treatment Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Rheumatic Disorders Treatment Sales (K Units) by Type (2018-2023)
    Table 51. Global Rheumatic Disorders Treatment Sales (K Units) by Type (2024-2029)
    Table 52. Global Rheumatic Disorders Treatment Sales Market Share by Type (2018-2023)
    Table 53. Global Rheumatic Disorders Treatment Sales Market Share by Type (2024-2029)
    Table 54. Global Rheumatic Disorders Treatment Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Rheumatic Disorders Treatment Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Rheumatic Disorders Treatment Revenue Market Share by Type (2018-2023)
    Table 57. Global Rheumatic Disorders Treatment Revenue Market Share by Type (2024-2029)
    Table 58. Global Rheumatic Disorders Treatment Price (US$/Unit) by Type (2018-2023)
    Table 59. Global Rheumatic Disorders Treatment Price (US$/Unit) by Type (2024-2029)
    Table 60. Global Rheumatic Disorders Treatment Sales (K Units) by Application (2018-2023)
    Table 61. Global Rheumatic Disorders Treatment Sales (K Units) by Application (2024-2029)
    Table 62. Global Rheumatic Disorders Treatment Sales Market Share by Application (2018-2023)
    Table 63. Global Rheumatic Disorders Treatment Sales Market Share by Application (2024-2029)
    Table 64. Global Rheumatic Disorders Treatment Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Rheumatic Disorders Treatment Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Rheumatic Disorders Treatment Revenue Market Share by Application (2018-2023)
    Table 67. Global Rheumatic Disorders Treatment Revenue Market Share by Application (2024-2029)
    Table 68. Global Rheumatic Disorders Treatment Price (US$/Unit) by Application (2018-2023)
    Table 69. Global Rheumatic Disorders Treatment Price (US$/Unit) by Application (2024-2029)
    Table 70. Humira Corporation Information
    Table 71. Humira Description and Business Overview
    Table 72. Humira Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 73. Humira Rheumatic Disorders Treatment Product
    Table 74. Humira Recent Developments/Updates
    Table 75. Enbrel Corporation Information
    Table 76. Enbrel Description and Business Overview
    Table 77. Enbrel Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 78. Enbrel Rheumatic Disorders Treatment Product
    Table 79. Enbrel Recent Developments/Updates
    Table 80. Simponi Corporation Information
    Table 81. Simponi Description and Business Overview
    Table 82. Simponi Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 83. Simponi Rheumatic Disorders Treatment Product
    Table 84. Simponi Recent Developments/Updates
    Table 85. Remicade Corporation Information
    Table 86. Remicade Description and Business Overview
    Table 87. Remicade Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 88. Remicade Rheumatic Disorders Treatment Product
    Table 89. Remicade Recent Developments/Updates
    Table 90. Rituxan Corporation Information
    Table 91. Rituxan Description and Business Overview
    Table 92. Rituxan Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 93. Rituxan Rheumatic Disorders Treatment Product
    Table 94. Rituxan Recent Developments/Updates
    Table 95. Stelara Corporation Information
    Table 96. Stelara Description and Business Overview
    Table 97. Stelara Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 98. Stelara Rheumatic Disorders Treatment Product
    Table 99. Stelara Recent Developments/Updates
    Table 100. Cosentyx Corporation Information
    Table 101. Cosentyx Description and Business Overview
    Table 102. Cosentyx Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 103. Cosentyx Rheumatic Disorders Treatment Product
    Table 104. Cosentyx Recent Developments/Updates
    Table 105. Prolia Corporation Information
    Table 106. Prolia Description and Business Overview
    Table 107. Prolia Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 108. Prolia Rheumatic Disorders Treatment Product
    Table 109. Prolia Recent Developments/Updates
    Table 110. Orencia Corporation Information
    Table 111. Orencia Description and Business Overview
    Table 112. Orencia Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 113. Orencia Rheumatic Disorders Treatment Product
    Table 114. Orencia Recent Developments/Updates
    Table 115. Actemra Corporation Information
    Table 116. Actemra Description and Business Overview
    Table 117. Actemra Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 118. Actemra Rheumatic Disorders Treatment Product
    Table 119. Actemra Recent Developments/Updates
    Table 120. Benlysta Corporation Information
    Table 121. Benlysta Description and Business Overview
    Table 122. Benlysta Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 123. Benlysta Rheumatic Disorders Treatment Product
    Table 124. Benlysta Recent Developments/Updates
    Table 125. Forteo Corporation Information
    Table 126. Forteo Description and Business Overview
    Table 127. Forteo Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 128. Forteo Rheumatic Disorders Treatment Product
    Table 129. Forteo Recent Developments/Updates
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. Rheumatic Disorders Treatment Distributors List
    Table 133. Rheumatic Disorders Treatment Customers List
    Table 134. Rheumatic Disorders Treatment Market Trends
    Table 135. Rheumatic Disorders Treatment Market Drivers
    Table 136. Rheumatic Disorders Treatment Market Challenges
    Table 137. Rheumatic Disorders Treatment Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Rheumatic Disorders Treatment
    Figure 2. Global Rheumatic Disorders Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Rheumatic Disorders Treatment Market Share by Type in 2022 & 2029
    Figure 4. Acts on TNF-α Product Picture
    Figure 5. Acts on Interleukins and Interleukin Receptors Product Picture
    Figure 6. Act on Protein Kinase Product Picture
    Figure 7. Against Cell Surface Antigens Product Picture
    Figure 8. Acts on Hormones and Hormone Receptors Product Picture
    Figure 9. Global Rheumatic Disorders Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 10. Global Rheumatic Disorders Treatment Market Share by Application in 2022 & 2029
    Figure 11. Hospital
    Figure 12. Pharmacy
    Figure 13. Other
    Figure 14. Global Rheumatic Disorders Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Rheumatic Disorders Treatment Market Size (2018-2029) & (US$ Million)
    Figure 16. Global Rheumatic Disorders Treatment Sales (2018-2029) & (K Units)
    Figure 17. Global Rheumatic Disorders Treatment Average Price (US$/Unit) & (2018-2029)
    Figure 18. Rheumatic Disorders Treatment Report Years Considered
    Figure 19. Rheumatic Disorders Treatment Sales Share by Manufacturers in 2022
    Figure 20. Global Rheumatic Disorders Treatment Revenue Share by Manufacturers in 2022
    Figure 21. The Global 5 and 10 Largest Rheumatic Disorders Treatment Players: Market Share by Revenue in 2022
    Figure 22. Rheumatic Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 23. Global Rheumatic Disorders Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 24. North America Rheumatic Disorders Treatment Sales Market Share by Country (2018-2029)
    Figure 25. North America Rheumatic Disorders Treatment Revenue Market Share by Country (2018-2029)
    Figure 26. United States Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 27. Canada Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. Europe Rheumatic Disorders Treatment Sales Market Share by Country (2018-2029)
    Figure 29. Europe Rheumatic Disorders Treatment Revenue Market Share by Country (2018-2029)
    Figure 30. Germany Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. France Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. U.K. Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Italy Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Russia Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Asia Pacific Rheumatic Disorders Treatment Sales Market Share by Region (2018-2029)
    Figure 36. Asia Pacific Rheumatic Disorders Treatment Revenue Market Share by Region (2018-2029)
    Figure 37. China Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Japan Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. South Korea Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. India Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Australia Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. China Taiwan Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Southeast Asia Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Latin America Rheumatic Disorders Treatment Sales Market Share by Country (2018-2029)
    Figure 45. Latin America Rheumatic Disorders Treatment Revenue Market Share by Country (2018-2029)
    Figure 46. Mexico Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Brazil Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Argentina Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Middle East & Africa Rheumatic Disorders Treatment Sales Market Share by Country (2018-2029)
    Figure 50. Middle East & Africa Rheumatic Disorders Treatment Revenue Market Share by Country (2018-2029)
    Figure 51. Turkey Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Saudi Arabia Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. UAE Rheumatic Disorders Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Global Sales Market Share of Rheumatic Disorders Treatment by Type (2018-2029)
    Figure 55. Global Revenue Market Share of Rheumatic Disorders Treatment by Type (2018-2029)
    Figure 56. Global Rheumatic Disorders Treatment Price (US$/Unit) by Type (2018-2029)
    Figure 57. Global Sales Market Share of Rheumatic Disorders Treatment by Application (2018-2029)
    Figure 58. Global Revenue Market Share of Rheumatic Disorders Treatment by Application (2018-2029)
    Figure 59. Global Rheumatic Disorders Treatment Price (US$/Unit) by Application (2018-2029)
    Figure 60. Rheumatic Disorders Treatment Value Chain
    Figure 61. Rheumatic Disorders Treatment Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Rheumatoid Arthritis Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33E11182
Mon Feb 05 00:00:00 UTC 2024

Add to Cart

Global Rheumatology Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-29B5986
Mon Feb 05 00:00:00 UTC 2024

Add to Cart

Global Psoriatic Arthritis Therapeutics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9A6304
Fri Feb 02 00:00:00 UTC 2024

Add to Cart

Global Rheumatic Disorders Drug Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34K5776
Wed Jan 31 00:00:00 UTC 2024

Add to Cart